Emtricitabine/Tenofovirdisoproxil Cf

Emtricitabine/Tenofovir Disoproxil Cf is a combination medication used for HIV treatment and prevention. This oral medication helps manage HIV infection and reduce the risk of transmission.

Emtricitabine/Tenofovir Disoproxil Cf is primarily used in the treatment of HIV-1 infection in adults and adolescents. It is also used for pre-exposure prophylaxis (PrEP) to prevent HIV infection in high-risk individuals. This medication works by reducing the amount of HIV in the body, helping to control the infection and improve the immune system.

Common effects of Emtricitabine/Tenofovir Disoproxil Cf may include headache, nausea, diarrhea, and dizziness. Some individuals may experience changes in body fat distribution, such as increased belly size, loss of fat in the legs, arms, and face. It is important to discuss any persistent or severe side effects with a healthcare provider.

Emtricitabine/Tenofovir Disoproxil Cf should be used with caution in individuals with kidney problems or a history of bone disorders. Regular monitoring of kidney function and bone density may be recommended. This medication should not be used by individuals allergic to emtricitabine or tenofovir disoproxil.

Emtricitabine/Tenofovir Disoproxil Cf may interact with other medications, including those used to treat HIV, hepatitis B, and certain antibiotics. It is important to inform a healthcare provider about all medications being taken to avoid potential interactions. Alcohol consumption should be moderated while using this medication.